JPWO2021045159A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2021045159A5 JPWO2021045159A5 JP2021544029A JP2021544029A JPWO2021045159A5 JP WO2021045159 A5 JPWO2021045159 A5 JP WO2021045159A5 JP 2021544029 A JP2021544029 A JP 2021544029A JP 2021544029 A JP2021544029 A JP 2021544029A JP WO2021045159 A5 JPWO2021045159 A5 JP WO2021045159A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- haloc
- formula
- inhibitors
- halogen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025050332A JP2025094217A (ja) | 2019-09-04 | 2025-03-25 | 併用医薬による糖尿病の治療又は予防方法 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2019161526 | 2019-09-04 | ||
| JP2019161526 | 2019-09-04 | ||
| PCT/JP2020/033463 WO2021045159A1 (ja) | 2019-09-04 | 2020-09-03 | 併用医薬による糖尿病の治療又は予防方法 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025050332A Division JP2025094217A (ja) | 2019-09-04 | 2025-03-25 | 併用医薬による糖尿病の治療又は予防方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JPWO2021045159A1 JPWO2021045159A1 (https=) | 2021-03-11 |
| JPWO2021045159A5 true JPWO2021045159A5 (https=) | 2023-09-11 |
| JP7692832B2 JP7692832B2 (ja) | 2025-06-16 |
Family
ID=74852211
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021544029A Active JP7692832B2 (ja) | 2019-09-04 | 2020-09-03 | 併用医薬による糖尿病の治療又は予防方法 |
| JP2025050332A Withdrawn JP2025094217A (ja) | 2019-09-04 | 2025-03-25 | 併用医薬による糖尿病の治療又は予防方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025050332A Withdrawn JP2025094217A (ja) | 2019-09-04 | 2025-03-25 | 併用医薬による糖尿病の治療又は予防方法 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20230119894A1 (https=) |
| EP (2) | EP4026564A4 (https=) |
| JP (2) | JP7692832B2 (https=) |
| KR (1) | KR20220056219A (https=) |
| CN (2) | CN119113123A (https=) |
| AU (1) | AU2020341926B2 (https=) |
| BR (1) | BR112022003323A2 (https=) |
| CA (1) | CA3151909A1 (https=) |
| MX (1) | MX2022002683A (https=) |
| WO (1) | WO2021045159A1 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP7760370B2 (ja) * | 2019-09-04 | 2025-10-27 | 日本たばこ産業株式会社 | 慢性腎臓病の治療又は予防方法 |
| CA3175131A1 (en) * | 2020-03-19 | 2021-09-23 | Chihiro Okuma | Treatment or prevention method for chronic heart failure |
| AU2022340358A1 (en) * | 2021-09-02 | 2024-01-04 | Daewoong Therapeutics Inc. | Pharmaceutical composition for preventing or treating diabetic eye disease comprising sglt-2 inhibitor |
| WO2025245592A1 (en) * | 2024-05-31 | 2025-12-04 | Aché Laboratórios Farmacêuticos S.A. | Multi-target compounds, process for the preparation of the compounds, intermediates, pharmaceutical composition, pharmaceutically acceptable salts, combination, medicament, use of a compound and method of treatment |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW201105338A (en) * | 2009-07-01 | 2011-02-16 | Kissei Pharmaceutical | Medicine derived from a combination of SGLT1-inhibitor and DPP-IV inhibitor |
| TWI562775B (en) * | 2010-03-02 | 2016-12-21 | Lexicon Pharmaceuticals Inc | Methods of using inhibitors of sodium-glucose cotransporters 1 and 2 |
| AR087701A1 (es) * | 2011-08-31 | 2014-04-09 | Japan Tobacco Inc | Derivados de pirazol con actividad inhibidora de sglt1 |
| UA113086C2 (xx) * | 2012-05-10 | 2016-12-12 | Піразольні сполуки як інгібітори sglt1 | |
| CN110066302B (zh) * | 2018-01-23 | 2022-12-27 | 广东东阳光药业有限公司 | 吡喃葡萄糖基衍生物及其用途 |
| TWI805699B (zh) * | 2018-03-01 | 2023-06-21 | 日商日本煙草產業股份有限公司 | 甲基內醯胺環化合物及其用途 |
| EP3778593A4 (en) * | 2018-04-04 | 2021-12-22 | Japan Tobacco Inc. | HETEROARYL-SUBSTITUTED PYRAZOLE COMPOUND AND ITS MEDICAL USE |
| JP7760370B2 (ja) * | 2019-09-04 | 2025-10-27 | 日本たばこ産業株式会社 | 慢性腎臓病の治療又は予防方法 |
| CA3175131A1 (en) * | 2020-03-19 | 2021-09-23 | Chihiro Okuma | Treatment or prevention method for chronic heart failure |
-
2020
- 2020-09-03 US US17/639,552 patent/US20230119894A1/en active Pending
- 2020-09-03 CN CN202411355046.5A patent/CN119113123A/zh active Pending
- 2020-09-03 WO PCT/JP2020/033463 patent/WO2021045159A1/ja not_active Ceased
- 2020-09-03 BR BR112022003323A patent/BR112022003323A2/pt unknown
- 2020-09-03 CA CA3151909A patent/CA3151909A1/en active Pending
- 2020-09-03 EP EP20860175.7A patent/EP4026564A4/en not_active Withdrawn
- 2020-09-03 EP EP23196223.4A patent/EP4342466A1/en active Pending
- 2020-09-03 AU AU2020341926A patent/AU2020341926B2/en active Active
- 2020-09-03 KR KR1020227010592A patent/KR20220056219A/ko active Pending
- 2020-09-03 JP JP2021544029A patent/JP7692832B2/ja active Active
- 2020-09-03 CN CN202080076112.9A patent/CN114585387B/zh active Active
- 2020-09-03 MX MX2022002683A patent/MX2022002683A/es unknown
-
2025
- 2025-03-25 JP JP2025050332A patent/JP2025094217A/ja not_active Withdrawn